These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36520180)

  • 1. Distinguishing mesorectal tumor deposits from metastatic lymph nodes by using diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer.
    Xu Q; Xu Y; Wang J; Sun H; Lin J; Xie S
    Eur Radiol; 2023 Jun; 33(6):4127-4137. PubMed ID: 36520180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of texture analysis on T2-weighted MR for differentiating tumor deposits from mesorectal nodes in rectal cancer patients, in a retrospective cohort.
    Atre ID; Eurboonyanun K; Noda Y; Parakh A; O'Shea A; Lahoud RM; Sell NM; Kunitake H; Harisinghani MG
    Abdom Radiol (NY); 2021 Feb; 46(2):459-468. PubMed ID: 32700214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential diagnosis of nasopharyngeal carcinoma and nasopharyngeal lymphoma based on DCE-MRI and RESOLVE-DWI.
    Song C; Cheng P; Cheng J; Zhang Y; Sun M; Xie S; Zhang X
    Eur Radiol; 2020 Jan; 30(1):110-118. PubMed ID: 31372786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-Weighted Magnetic Resonance Imaging of 103 Patients with Rectal Adenocarcinoma Identifies the Apparent Diffusion Coefficient as an Imaging Marker for Tumor Invasion and Regional Lymph Node Involvement.
    Kargol J; Rudnicki W; Kenig J; Filipowska J; Kaznowska E; Kluz T; Guz W; Łuczyńska E
    Med Sci Monit; 2021 Dec; 27():e934941. PubMed ID: 34871292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple parameters from ultrafast dynamic contrast-enhanced magnetic resonance imaging to discriminate between benign and malignant breast lesions: Comparison with apparent diffusion coefficient.
    Cao Y; Wang X; Shi J; Zeng X; Du L; Li Q; Nickel D; Zhou X; Zhang J
    Diagn Interv Imaging; 2023 Jun; 104(6):275-283. PubMed ID: 36739225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing T1-2 and T3a tumors of rectal cancer with texture analysis and functional MRI parameters.
    Sun D; Wu X; Wang L; Li G; Huang J; Li Y
    Diagn Interv Radiol; 2022 May; 28(3):200-207. PubMed ID: 35748201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative prediction of extramural venous invasion in rectal cancer by dynamic contrast-enhanced and diffusion weighted MRI: a preliminary study.
    Ao W; Zhang X; Yao X; Zhu X; Deng S; Feng J
    BMC Med Imaging; 2022 Apr; 22(1):78. PubMed ID: 35484509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among Standardized Index of Shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters.
    Fusco R; Sansone M; Granata V; Grimm R; Pace U; Delrio P; Tatangelo F; Botti G; Avallone A; Pecori B; Petrillo A
    Abdom Radiol (NY); 2019 Nov; 44(11):3683-3700. PubMed ID: 30361867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis value of 3.0 T diffusion-weighted imaging with background suppression magnetic resonance for metastatic lymph nodes in rectal cancer].
    Zhuang XZ; Yu SP; Cui J; Chen CQ; Zhao XJ; Pan BT; Li ZP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Nov; 14(11):842-5. PubMed ID: 22116716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination between Metastatic and Nonmetastatic Mesorectal Lymph Nodes in Rectal Cancer Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging.
    Yu XP; Wen L; Hou J; Bi F; Hu P; Wang H; Wang W
    Acad Radiol; 2016 Apr; 23(4):479-85. PubMed ID: 26853971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging in the differential diagnosis of parotid tumors.
    Xiang S; Ren J; Xia Z; Yuan Y; Tao X
    BMC Med Imaging; 2021 Dec; 21(1):194. PubMed ID: 34920706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Multiparametric Magnetic Resonance Imaging in the Study of Primary Tumor and Pelvic Lymph Node Metastasis in Stage IB1-IIA1 Cervical Cancer.
    Zhang X; Dong Y; Song Q; Zhu Y; Pang H; Luo Y; Yu T; Liu F; Guo Y
    J Comput Assist Tomogr; 2020; 44(5):750-758. PubMed ID: 32842062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer.
    Zhou G; Chen X; Zhang J; Zhu J; Zong G; Wang Z
    Eur J Radiol; 2014 Nov; 83(11):2013-8. PubMed ID: 25213829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: correlation of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters with hypoxia-inducible factor 1α expression and tumor grade/stage.
    Liu L; Hu L; Zeng Q; Peng D; Chen Z; Huang C; Liu Z; Wen Q; Zou F; Yan L
    Ann Palliat Med; 2021 Feb; 10(2):2238-2253. PubMed ID: 33725777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution diffusion-weighted imaging compared with conventional diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging with regard to image quality and assessment of breast cancer morphology.
    Metin Y; Orhan Metin N; Kul S; Taşçı F; Özdemir O; Küpeli A
    Diagn Interv Radiol; 2023 Mar; 29(2):251-259. PubMed ID: 36987843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative parameters of magnetic resonance imaging cannot predict human epidermal growth factor receptor 2 (HER2) status in rectal cancer.
    Huang Z; Tu X; Lin Q; Zhan Z; Li Y; Liu J
    Clin Imaging; 2022 Mar; 83():77-82. PubMed ID: 34990984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of lymph node metastasis on rectal cancer by PET-CT computer imaging combined with MRI technology.
    Li F; Hu J; Jiang H; Sun Y
    J Infect Public Health; 2020 Sep; 13(9):1347-1353. PubMed ID: 31289005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved detection of a tumorous involvement of the mesorectal fascia and locoregional lymph nodes in locally advanced rectal cancer using DCE-MRI.
    Armbruster M; D'Anastasi M; Holzner V; Kreis ME; Dietrich O; Brandlhuber B; Graser A; Brandlhuber M
    Int J Colorectal Dis; 2018 Jul; 33(7):901-909. PubMed ID: 29774398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between malignant and benign breast masses: combination of semi-quantitative analysis on DCE-MRI and histogram analysis of ADC maps.
    Liu HL; Zong M; Wei H; Lou JJ; Wang SQ; Zou QG; Shi HB; Jiang YN
    Clin Radiol; 2018 May; 73(5):460-466. PubMed ID: 29295753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.